Adalimumab Biosimilar Yuflyma Gets Approval for Additional Pediatric Indications
Adalimumab Biosimilar Yuflyma Gets Approval for Additional Pediatric Indications The FDA has expanded the approval of Yuflyma (adalimumab-aaty) and its unbranded version to include the tre…